Detalles de la búsqueda
1.
A Nordic-Baltic perspective on indications for proton therapy with strategies for identification of proper patients.
Acta Oncol
; 59(10): 1157-1163, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32902341
2.
Five versus six fractions of radiotherapy per week for squamous-cell carcinoma of the head and neck (IAEA-ACC study): a randomised, multicentre trial.
Lancet Oncol
; 11(6): 553-60, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20382075
3.
Incidence and Survival for Head and Neck Cancers in Estonia, 1996-2016: A Population-Based Study.
Clin Epidemiol
; 13: 149-159, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33658861
4.
Radiotherapy quality assurance of the IAEA-HypoX trial of the accelerated radiotherapy in the treatment of head and neck squamous cell carcinoma with or without the hypoxic radiosensitizer nimorazole.
Acta Oncol
; 54(9): 1673-7, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26397148
5.
Resources and management strategies for the use of radiotherapy in the treatment of lung cancer in Central and Eastern European countries: results of an International Atomic Energy Agency (IAEA) survey.
Lung Cancer
; 56(2): 235-45, 2007 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-17267070
6.
IAEA-HypoX. A randomized multicenter study of the hypoxic radiosensitizer nimorazole concomitant with accelerated radiotherapy in head and neck squamous cell carcinoma.
Radiother Oncol
; 116(1): 15-20, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25913070
Resultados
1 -
6
de 6
1
Próxima >
>>